4 trends tracked about this subject — the full history, oldest to newest below.
Medical experts are reporting a breakthrough in pancreatic cancer treatment involving a new pill and fast-tracked regulatory reviews.
Reports and regulatory discussions are linking the Depo-Provera contraceptive injection to a risk of rare brain tumors.
Experimental cancer treatment Daraxonrasib is gaining momentum as regulators fast-track review and clinical data suggests potential advancements in patient care.
Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.